Cargando…
483. Disease Severity and Clinical Manifestations of SARS-CoV-2 Infection Among Infants Over the First Year of the Pandemic in Canada
BACKGROUND: There is limited data on outcomes of SARS-CoV-2 infection among infants (< 1 year of age). In the absence of any approved vaccines for infants, understanding the risk factors for hospitalization and severe disease from COVID-19 in this age group will help inform clinical management an...
Autores principales: | Piché-Renaud, Pierre-Philippe, Panetta, Luc, Farrar, Daniel, Hepburn, Charlotte Moore, Drouin, Olivier, Kakkar, Fatima, Morris, Shaun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644518/ http://dx.doi.org/10.1093/ofid/ofab466.682 |
Ejemplares similares
-
58 Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada
por: Piché-Renaud, Pierre-Philippe, et al.
Publicado: (2022) -
Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada
por: Piché-Renaud, Pierre-Philippe, et al.
Publicado: (2022) -
Clinical Characteristics and Disease Severity Among Infants With SARS-CoV-2 Infection in Montreal, Quebec, Canada
por: Panetta, Luc, et al.
Publicado: (2020) -
Pediatricians’ perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada
por: Ali, Yamna, et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada
por: Piché-Renaud, Pierre-Philippe, et al.
Publicado: (2021)